Jump to... 

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

 

Have you been awarded a Limited Submission recognition?

Please let us know at LSO@vanderbilt.edu


covid

Special Research Focus: COVID-19 Funding Opportunities

Curated collections of funding opportunities

Edge for Scholars offers curated list of COVID-19 funding opportunities

Updated regularly. Check the site often for updates about research funding opportunities, including to special calls & announcements, in response to the coronavirus pandemic. 

Vanderbilt University sites showcase public and private COVID-19 funding

Lists of application opportunities related to COVID-19 have been shared by Office of the Vice Provost for Research (Public funders) and the Office of Corporate and Foundation Relations (Private funders). Updated regularly. 

GrantForward funding database provides list of COVID-19 funding opportunities


Highlighted opportunities

NIH mobilizes $1.5B national innovation initiative for COVID-19 diagnostics

Applications accepted and funded on a rolling basis

Apply at https://www.poctrn.org/radx

More about RADx here.

NIAID R01 and R21 emergency awards for rapid investigation of SARS-CoV-2 and COVID-19

Applications will be accepted on a rolling basis

PAR-20-177 for R21 funding (clinical trial not allowed)

PAR-20-178 for R01 funding (clinical trial not allowed)

COVID-19-Related Enhancements to Existing PCORI Research Projects

Applications accepted on a rolling basis


Research Awards Banner.png

Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

Mary Kay Foundation Innovative/Translational Cancer Research Grant

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Applications due December 3

Vanderbilt (VU + VUMC, collaboratively) has been invited to nominate one candidate for the Mary Kay Foundation Innovative/Translational Cancer Research Grant program for 2021. These awards provide $100,000 over two years to support innovative translational research for cancers affecting women, including but not limited to ovarian, uterine, breast, and/or cervical cancer.

The Mary Kay Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention, or treatment of cancer. 

You can find a list of the previous award recipients here. Review additional guidelines in the RFP.

Eligibility:

  • Principal Investigator must be Full-time Assistant Professor or higher (Assistant, Associate, or Full Professor)
  • Staff scientists, postdoctoral trainees and instructors are NOT eligible
  • Up to one co-PI is permitted
  • Maximum $100,000 award includes direct and indirect costs over a two-year period. (Indirect rate may not exceed 15%).
  • U.S. citizenship is not required.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following to LSO@vanderbilt.edu by 5 p.m. on December 3Please combine your materials into a single PDF and reference the program name in the subject line of the email. 

  1. Brief research plan including summary budget (2 page max including budget, see suggested example in RFP);
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

The chosen nominee will submit a full proposal to the Foundation by the deadline of February 5, 2021. Direct all questions about the application process to LSO@vanderbilt.edu.


NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)

Applications due December 3

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit one application per scientific focus area to the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) programs. The scientific focus areas are Data Science, Cancer Control Science, and Other Sciences. There are three separate RFAs, which allow different types of proposed research (e.g. basic, clinical): RFA-CA-20-055, RFA-CA-20-056, and RFA-CA-20-057. VUMC’s three selected applicants (1/focus area) may apply to whichever RFAs best suit their research proposals.

The objective of the NCI Pathway to Independence Award is to help outstanding postdoctoral researchers complete needed, mentored career development and transition in a timely manner to independent tenure-track (or equivalent) faculty positions. The K99/R00 award is intended to foster the development of a creative, independent research program that will be competitive for subsequent independent funding and that will help advance the mission of the NCI.

This program is designed for outstanding postdoctoral fellows with research and/or clinical doctoral degrees who do not require extended periods of mentored research career development beyond their original doctoral degrees before transitioning to research independence. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply.

Individuals must be in mentored, postdoctoral positions to be eligible to apply to the K99/R00 program. The K99/R00 award will provide up to 5 years of support in two phases. The initial (K99) phase will provide support for up to 2 years of mentored postdoctoral research and career development. The second (R00) phase will provide up to 3 years of independent research support, which is contingent on satisfactory progress during the K99 phase and obtaining an approved, independent tenure-track (or equivalent) faculty position.

The award covers up to $100,000 per year toward the salary of the career award recipient, and up to $30,000 per year toward the research development costs of the award recipient.

See solicitations for full program and eligibility details:

Internal Application Process:

Anyone interested in being considered to submit VUMC’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 3. 

In your email, indicate to which RFA and which scientific focus area (data science, cancer control science, other sciences) you would apply.

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


W.M. Keck Foundation Research Program- Winter 2021

Applications due December 7

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit up to two proposals, one in Medical Research and one in Science and Engineering, for the W.M. Keck Foundation Research Program.  We are currently soliciting concept papers to be presented to the Keck Foundation for feedback in a consultation phone call.  The goal of the program is to benefit humanity by supporting work that has a distinctive and novel approach, questions a prevailing paradigm, or has the potential to break open new territory in a field.  Grants are typically awarded for roughly $1,000,000 and abstracts from previously funded proposals can be found here. Indirect costs are not allowed.

Program Priorities for Funding:

  • Focus on important and emerging areas of research
  • Have the potential to develop breakthrough technologies, instrumentation or methodologies
  • Are innovative, distinctive and interdisciplinary
  • Demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm
  • Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem
  • Does not focus on clinical or translational research, treatment trials or research for the sole purpose of drug development
  • Fall outside the mission of public funding agencies
  • Demonstrate that private philanthropy generally, and the W. M. Keck Foundation in particular, is essential to the project’s success

Internal Application Process:

Anyone interested in being considered as VUMC’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on December 7.

  1. 1-page Concept Paper (See guidelines below)
  2. Statement of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs. This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. NIH Biosketch

Concept Paper Requirements:

  • Must be single page with 12 point font and 1 inch margins
  • Must indicate the area of emphasis for the project – “medical research” or “science and engineering research”
  • Include an overview of the proposed project emphasizing any unique aspects and pilot studies. Emphasize attributes that address program priorities, e.g. high level of risk, transformative impact.
  • Include a description of the methodologies and key personnel
  • Include a brief justification of the need for Keck support. Competitive proposals will provide evidence that proposed research is a poor fit for federal funding opportunities, i.e. reviewer comments or program officer discussion.
  • Include an estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies, etc. (budgets can be rough approximations at this stage)

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NIH Collaborative Program Grant for Multidisciplinary Teams (RM1)

Applications due December 7

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit one proposal for the January 2021 cycle of the NIH Collaborative Program Grant for Multidisciplinary Teams (RM1). The program is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of National Institute of General Medical Sciences (NIGMS). Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. While applications may request research program budgets of up to $1.5 million direct costs per year, it is anticipated that most awards will be between $700,000-$900,000 direct costs.

Eligibility:

Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations. NIGMS also supports research in a limited number of clinical areas that affect multiple organ systems (see here for scientific areas supported by NIGMS).

We recommend that applicants review the RFA in detail to review the research areas that are within the NIGMS mission. Applications that focus solely on a specific organ or disease state and that are within the mission areas of other NIH Institutes and Centers are not appropriate for this FOA. Applications that employ specific cells or tissues to address a fundamental biomedical question are appropriate.

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies or infrastructure development are not appropriate for this FOA. NIH-defined clinical trials are not allowed.

Internal Application Process:

Anyone interested in being considered to submit VUMC’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 7:

  • Brief project description including summary budget and role of each PI (2 page max);
  • Letter of support from department chair/center director;
  • NIH Biosketch for all PIs

Full applications are due to NIH by January 25, with an LOI requested 30 days prior. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu


2021 Macy Faculty Scholars Program

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Applications due December 10

Vanderbilt has the opportunity to nominate one candidate each from the School of Medicine and the School of Nursing for the Josiah Macy Jr. Foundation’s Faculty Scholars Program. The goal is to develop the next generation of national leaders in medical and nursing education. The program will support the Macy Faculty Scholars in leading new educational innovations at their home institutions and will provide opportunities for further career development through national meetings and participation in other Macy activities. This award typically provides up to $200,000 of salary support (plus fringe) over two years.

The foundation will offer an Informational Webinar on December 9 at 12:00 p.m. ET. Anyone interested is invited to register here

Eligibility:

The eligible candidate must:

  • Have served for five or more years as a full-time faculty member, ideally at the sponsoring school.
  • Have identified a senior faculty member who will serve as a mentor and provide advice on the candidate’s project and career development.
  • Have an educational innovation project with the appropriate institutional support.
  • Have an institutional commitment for the protection of at least 50% of the candidate’s time.
  • Be a US citizen or permanent resident.

The Foundation has particular interest in innovations that take place in learning environments where clinical care is delivered. Within these clinical learning environments, the Foundation is interested in projects which:

  • Prepare future health professionals to navigate and address ethical dilemmas that arise when the principles of the health professions are in conflict with barriers imposed by the health delivery system.
  • Advance equity, diversity, and belonging.
  • Enhance collaboration among health professionals, educators, and learners.

Internal Application Process:

Anyone interested in being considered as one of Vanderbilt’s nominees must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on December 10

  • Brief (2 page maximum) description of the educational innovation project;
  • Statement of support from candidate’s mentor indicating a commitment to advise the candidate on project work and career development;
  • Brief statement from the candidate’s department chair that the candidate will have “at least 50% protected time to pursue a mentored educational project.” Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  • Brief CV (5 page max) or NIH Biosketch

Submissions should reference the program name and applicant’s School (Medicine or Nursing) in the subject line of the email. 

**Process for cost-sharing typically coordinated at the departmental/school level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Please contact us at LSO@vanderbilt.edu if you have any questions about the program, foundation, or internal review process.


CDC Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally

Applications due December 10

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Overview:

VU and VUMC may each submit one application to the CDC's Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally.  The award provides up to $2,000,000/year direct and indirect costs for a period of 5 years.

The purpose of this NOFO is to:

  1. Conduct and monitor epidemiologic and laboratory-based science, surveillance, and research related to COVID-19 and other global public health threats in Africa, Southeast Asia, Eastern Europe and Central Asia, and the Middle East and North Africa (MENA), including, but not limited to, assessments of the extent of pathogen exposures or transmission based on serologic testing, improved understanding of immune responses to infectious pathogens, and assessments of various approaches to collecting and analyzing the results of serologic testing; and,
  2. Incorporate the results of these public health activities into operational disease detection, prevention, and response or control programs in regions noted above, strengthen public health capacity as outlined in the Global Health Security Agenda, and disseminate findings across the region, with partners, and globally.

This NOFO supports activities that will fulfill four broad goals:

  1. Conduct high quality sero-epidemiologic studies that inform an understanding of approaches to the collection of seroprevalence data and the extent of pathogen transmission in general populations and populations of specific interest, contributing to both national and global knowledge and databases, and building local capacity to collect, analyze, and routinely report on sero-epidemiologic data.
  2. Develop host country public health capacity, prioritizing surveillance, laboratory and public health response capacities,
  3. Strengthen host country institutional capacity to conduct research, plan, implement, and evaluate public health programs, including the capacity to detect and respond to emerging and re-emerging infectious diseases; and
  4. Incorporate, translate and promote the results of research into operational disease prevention and control programs and policy

See the full solicitation for more information.

Internal Application Process:

VU and VUMC Investigators: Submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 10. Submissions should reference the program name in the subject line of the email.

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch or 5-page CV

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


CDC Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality

Applications due December 10

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit one application to the CDC's Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality. The award provides up to $3,000,000/year direct and indirect costs for a period of 5 years.

The purpose of this NOFO is to understand the needs of emergency-affected and displaced populations and estimate morbidity and mortality in the context of the COVID-19 pandemic. The overall goals of this operational research are to a) improve mortality and cause of death estimation during the acute emergency phase, b) understand COVID-19 disease transmission, contributing factors and secondary health consequences, c) study the effects of various hand hygiene interventions on mitigating the spread of COVID-19 and d) understand the mental health impact of COVID-19 to reduce associated morbidity and mortality among displaced populations and in emergency settings.

Given the stress on surveillance systems and hypothesized secondary health effects on displaced populations and populations in humanitarian emergency settings, this NOFO requests applicants to submit applications proposing research studies among populations in humanitarian settings (such as refugee camps and internally displaced populations) in order to do at least one of the following:

  1. Improve mortality estimation and cause of death methods in the acute emergency phase.
  2. Understand SARS-CoV-2 transmission among displaced populations by comparing surveillance strategies and develop an understanding of risk factors, and motivators and barriers for certain mitigation measures.
  3. Study the effects of hand hygiene interventions on mitigating the spread of COVID-19.
  4. Understand COVID-19 secondary health impacts among displaced persons.
  5. Understand the impact of COVID-19 on mental health.

In order to achieve the overarching objectives, the applicant should specify how they plan to achieve these outcomes through at least one of the following methods:

  1. Compare various mortality surveillance systems, mortality surveys and cause of death methods specific for humanitarian settings to develop accurate and refined systems.
  2. Compare surveillance and mitigation strategies to better understand disease transmission among emergency-affected populations, in order to develop evidence-based guidelines for the implementation of effective interventions in humanitarian settings.
  3. Leverage prospective research designs to understand SARS-CoV-2 transmission, and the trajectory, longer-term outcomes, and secondary health effects of COVID-19 disease among displaced persons
  4. Research hand hygiene efforts in emergency settings and evaluate the effects of hand hygiene interventions on SARS-CoV-2 transmission and other enteric and respiratory diseases in the acute emergency phase and post recovery phase
  5. Conduct innovative research, including randomized controlled trials, on the effectiveness and impact of various mental health interventions, programs and services, and develop evidence-based guidelines for humanitarian settings.

See the full solicitation for more information.

Internal Application Process:

Anyone interested in being considered to submit Vanderbilt’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 10. Submissions should reference the program name in the subject line of the email.

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2021 Oak Ridge Associated Universities (ORAU) Events Sponsorship Program

Applications due December 15

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt may submit 1 application to the Oak Ridge Associated Universities (ORAU) Events Sponsorship Program. Applicants may request up to $4,000 to support events which involve participants from more than one ORAU institution. Such events may include visits to an ORAU institution by a renowned speaker, conferences or workshops with a focused theme, or a technology transfer/business plan competition.

Eligibility Requirements:

  • Event must occur between May 1 and September 30.
  • Funding must be awarded prior to the event.

Evaluation Criteria:

  • Potential impact of the event, including the number of institutions or participants
  • Participation by more than one ORAU institution is required
  • Student participation is considered a positive factor.
  • New events have preference over events that are on-going with an established financial model.
  • Preference will be given to events in STEM disciplines.
  • A representative from ORAU must be invited to the event
  • Seminar series will not be considered for support due to the limited engagement by other ORAU member institutions

Internal Application Process:

Interested faculty should must submit the below items in a single file (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on December 15Submissions should reference the program name in the subject line of the email.

  1. Brief (2 page maximum) event description including
    1. the date and location of the event
    2. other participating ORAU Member Institutions
    3. purpose and scope of the event
    4. anticipated outcomes
    5. summary budget
  2. NIH Biosketch or brief CV (5 pages max)
  3. Letter of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


Dr. Scholl Foundation Grant Program

Applications due December 15

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may submit one application to the Dr. Scholl Foundation Grant Program. The Dr. Scholl Foundation is dedicated to providing financial assistance to organizations committed to improving our world. They value innovation, practicality, hard work and compassion. The foundation’s grant program offers 1 year grants of $5,000 to $25,000 in the following areas:

  • Education
  • Social Service
  • Healthcare
  • Civic and Cultural
  • Environmental

The categories above are not intended to limit the interest of the Foundation from considering other worthwhile projects. In general, the Foundation guidelines are broad for flexibility in providing grants.

Examples of previously funded healthcare projects include – nurse leaders program, palliative care/education, pediatric cardio fellowship, physician training in pediatric psycho-oncology, psychiatry residency training, cancer outreach programs, diabetes projects, underserved women’s health initiatives, etc.

The Dr. Scholl Foundation does not consider funding for event sponsorships (including the purchase of tables, tickets or advertisements) or for endowments, capital campaigns, or general support. See the full list of exclusions here.

See the program page, the foundation’s homepage, and its mission statement for more information.

Internal Application Process:

Anyone interested in being considered to submit Vanderbilt’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 15:

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch or 5-page CV

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NIEHS Outstanding New Environmental Scientist (ONES) Award

Applications due December 17

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

VUMC may submit one application to the NIH National Institute of Environmental Health Sciences (NIEHS) Outstanding New Environmental Scientist (ONES) Program.

The Outstanding New Environmental Scientist (ONES) Award is intended to identify the most talented Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the Environmental Health Sciences and assist them in launching an innovative research program focused on the understanding of environmental exposure effects on people's health.

Program goals include career promotion for ESIs, as well as support of the scientific project proposed. Applications for the ONES program differ from standard R01 applications in that applicants must provide information about their career goals in the environmental health sciences, their previous research experience and achievements, plans for the active participation of an external advisory committee to provide consultation and feedback, the commitment by the institution to actively support the research program development of the Program Director/Principal Investigator (PD/PI), and a plan for career enhancement which will provide a strong foundation for future research endeavors.

Research projects proposed will be expected to have a defined impact on the environmental health sciences and be responsive to the mission of the NIEHS and the 2018-2023 Strategic Plan: Advancing Science, Improving Health: A Plan for Environmental Health Sciences Research. Applicants should consult the strategic plan to ensure that the research proposed in their application addresses the goals and priority areas of the NIEHS.

Award Information

The budget for direct costs is composed of two elements - research direct costs and career enhancement costs. For most applications, the budget for direct costs should be limited to $250,000 per year. With strong justification, research projects which have inherently higher costs may request direct costs of up to $400,000 per year. Career enhancement direct costs are limited to $250,000, which can be distributed over the 5-year award period. Note: the total direct cost budget (research plus career enhancement) may not exceed $475,000 in any year of the award.

Eligibility:

  • PD/PIs must be NIH defined Early Stage Investigators. See https://grants.nih.gov/grants/new_investigators/index.htm
  • PD/PIs must have faculty appointments which are tenure track or equivalent, generally at the level of Assistant Professor, and have demonstrated outstanding abilities in basic, clinical, quantitative, or population-based research. Individuals must have established research independence from a mentor, and have dedicated, independent laboratory space or access to the clinical, population-based and/or public health research resources which will allow them to conduct the research proposed in the grant application as the lead, independent PD/PI.
  • Applications must have a research focus on exposure -health related responses from environmental agents within the mission interest of the NIEHS, and may focus on: industrial chemicals or manufacturing byproducts, metals, pesticides, herbicides, air pollutants and other inhaled toxicants, particulates or fibers, fungal, and bacterial or biologically derived toxins
  • Applications may not focus exclusively/primarily on: alcohol, chemotherapeutic agents, radiation that is not a result of an ambient environmental exposure, smoking, except when considered as a secondary smoke exposure as a component in the indoor environment (particularly in children), drugs of abuse, pharmaceuticals, dietary nutrients, and infectious or parasitic agents.

See the solicitation for more details.

Internal Application Process:

Anyone interested in being considered to submit VUMC’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 17:

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


 

Research Awards Banner.png

Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)

Letters of Intent due December 6

The NIDDK Catalyst Award is intended to support investigators developing bold, innovative, and often risky approaches to address significant and intractable problems in research topics of interest within two extramural divisions of NIDDK: the Division of Diabetes, Endocrinology and Metabolic Diseases and the Division of Digestive Diseases and Nutrition.

Applications should be focused on major scientific challenges, and have the potential to produce an unusually high impact on diseases and conditions that are central to the mission of these two divisions within NIDDK. To be considered responsive to this initiative, the proposed research should reflect new and novel scientific directions that are distinct from concepts and approaches being pursued in the investigator’s research program or elsewhere. The program is not intended to expand a current research program's funding in the area of the proposed project, but instead must reflect a fundamental new insight or understanding that will revolutionize the field. 

Catalyst awardees are required to commit a substantial portion of their research effort (at least 4 person-months) to activities supported by the award. Effort expended toward teaching, administrative, or clinical duties should not be included in this calculation. For example, 33% effort in a 12-month calendar appointment would equal approximately 4.0 person-months (12 x 0.33 = 4.0). Investigators who will not be able to meet this requirement should not submit applications.

Research Scope

This FOA will only support research within the mission of NIDDK. NIDDK has many research areas  within its mission, but all research related to relevant diseases may not be appropriate for NIDDK. Applicants to this FOA are strongly encouraged to contact NIDDK staff as soon as possible in the development of the application, so that NIDDK staff can help the applicant understand whether the application is within the goals and mission of the Institute and is appropriate for this FOA.  

Applications submitted to this FOA should be directly focused on diseases or conditions that are central to the mission of either the Division of Diabetes, Endocrinology and Metabolic Diseases (DEMD), or the Division of Digestive Diseases and Nutrition (DDN) of the NIDDK. Research focused on diseases or conditions central to the mission of NIDDK's Division of Kidney, Urologic and Hematologic Diseases (here) will not be considered responsive to this initiative. 

Research areas of interest for DEMD  include:

  • Diabetes
  • Endocrinology
  • Metabolism

Research areas of interest for DDN include:

  • Digestive Diseases
  • Hepatobiliary diseases
  • Exocrine pancreatic diseases
  • Pathophysiological mechanisms related to obesity and nutrition
  • Mechanisms of central and peripheral neural control of the normal digestive system
  • HIV/AIDS research in the context of the above areas of interest.

HESI THRIVE – Making Cancer Patient Quality of Life an Active Research Priority

Letters of Intent due December 31

THRIVE funding is for translational research to predict, prevent, and/or reduce unintended adverse effects from cancer therapy. THRIVE, a partner in the 2018 Biden Cancer Initiative, provides seed grants for nonclinical, clinical, and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. THRIVE also supports the development of approaches to avoid or lessen these effects. 

ELIGIBILITY

  • PI’s must hold and MD, PhD, DVM or equivalent degree. Candidates for these degrees along with their PI may apply.
  • Candidates must have the ability to conduct independent research and have published in peer-reviewed journals.

FUNDING

  • Range of $20,000 - $50,000 for up to 24 months
  • Upon agreement to THRIVE award terms, THRIVE will disburse 75% of funds with the remaining provided upon completion of the study milestones.

APPLICATION PROCESS

  • Thrive requires a letter of intent (LOI) in advance of the grant application. Only investigators who have submitted an LOI and been invited to submit a formal grant application will be considered for funding.
  • LOI’s are due December 31st, 2020

SELECTION PROCESS

  • The proposed study’s scientific merit, innovation and ability to translate preclinical to clinical research (or vice versa) is key to being selected for funding.
  • Preference given to studies in which both a non-clinical and a clinical researcher are engaged in either the design, conduct, or analysis or the study results (see attached guidelines for details). • A total of 4-6 grants will be awarded in 2021.

THRIVE is interested in research that will advance our:

  • Fundamental understanding of cancer drug or therapy-related toxicity;
  • Ability to identify  and translate critical biomarkers of toxicity;
  • Models (in vitro, in vivo, in silico) of pediatric or adult drug exposure that predict early or impending toxicities;
  • Understanding the role of protective co-therapies or modified exposure protocols on the onset of therapy-induced damage; and
  • Identification of novel protective therapies or dosing strategies. 

For more information visit https://hesithrive.org/ or contact research@hesithrive.org  


The Doris Duke Charitable Foundation - 2021 Physician Scientist Fellowship

Applications due January 5

Grants of up to $220,000 over two years ($100,000 direct cost and $10,000 indirect costs per year) will be awarded to physician scientists (MD, MD/PhD, DO, or foreign equivalent) in subspecialty fellowship training working at US medical institutions to support two years of clinical research that will strengthen their careers as biomedical investigators. 

PROGRAM DESCRIPTION

Physician scientists lend vital expertise to biomedical research through their training as both clinicians and researchers. The Physician Scientist Fellowship (PSF) award aims to support research during the final years of subspecialty fellowship and aid in the transition into an academic faculty appointment.  The specific goals of the PSF program are to: 1) support physician scientists in subspecialty fellowship to conduct an outstanding clinical research project; 2) ensure research time protection to enable development of research skills; and 3) facilitate strong mentorship relations. 

AWARD INFORMATION

The 2021 Physician Scientist Fellowship consists of $100,000 direct costs plus $10,000 (10 percent) indirect costs each year for two years. The award project period will begin on July 1, 2021. DDCF expects to fund about ten proposals in 2021. The priority of the PSF award is to fund candidates with promise for strong research careers. DDCF does not have funding priorities based on disease area or research type


Leukemia Research Foundation - Hollis Brownstein Research Grants Program

Letters of Intent due February 5

The Leukemia Research Foundation exclusively funds New Investigator grants for blood cancer research projects that focus on leukemia, lymphoma, multiple myeloma, and/or MDS.

  • New Investigators are considered to be within seven (7) years of their first independent faculty-level position at the time the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years.
  • Investigator must be in an independent faculty-level position at the time the application is submitted.
  • Adjustments for career interruptions can be made. These could include, but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.
  • Applicants are not required to be U.S. citizens and research projects from outside the U.S. are eligible.
  • Applicants with a KO8, K23, R00, or R99 grant are eligible and the total grant amount will not be applied toward the $175,000 per year threshold on total direct costs.
  • DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted.

Not Eligible:

  • Applicants with any active single grant (or multiple grants added together) that total $175,000 or greater in total direct costs per year are not eligible (as noted above, KO8, K23, R00, R99 grant awards are excluded from this total threshold).
  • Fellows are not eligible to apply.
  • Applicants with NIH RO1 funding, VA Merit Award or equivalent.
  • Applicants with career development awards from other national foundations (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
  • Renewal applications will not be accepted.
  • Co-PI’s are not permitted.

Minority applicants are valued members of the research community, vital to its success, and are encouraged to apply. If you have questions about eligibility, please email Grants@LRFmail.org.

2021-2022 Funding Cycle:

  • Grant period is one year (July 1, 2021 – June 30, 2022)
  • Grant awards up to $100,000

Key Dates:

February 5, 2021 - Letter of Intent Due by 12:00pm central standard time (1:00 pm eastern standard time)

By March 5, 2021 - Notification if invited to submit Full Application

April 5, 2021 - Full Application due (if invited to submit) by 12:00pm central standard time

June 30, 2021 - Grant recipients notified of award


KidneyX Artificial Kidney Prize 

Applications due March 24; Webinar on December 3

The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have launched the KidneyX Artificial Kidney Prize, a competition to accelerate the development of artificial kidneys toward human clinical trials.

This multiphase competition is KidneyX’s first fully dedicated effort toward artificial kidney advancement, with initial phases offering up to $10 million in prizes. The first phase seeks component or integrated prototype solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. Phase 1 submissions are due March 24, 2021Phases 1 and 2 will offer up to $10 million in prize awards.

Through this competition, HHS and the American Society of Nephrology seek to bring together scientific minds from around the world to radically transform kidney health. Collaboration will be critical to support artificial kidney advancement, and the competition encourages participation from experts across disciplines — including bioengineering, materials science, regenerative medicine, nanotechnology, medical devices, and nephrology.

To learn more, prospective entrants can join a virtual information session on December 3.